Related Experiment Video
Updated: Mar 7, 2026

Quantified Assessment of Infant's Gross Motor Abilities Using a Multisensor Wearable
Published on: May 17, 2024
Association between obesity-related biomarkers and cognitive and motor development in infants
Ana Cristina R Camargos1, Vanessa A Mendonça1, Katherine S C Oliveira2
1Departamento de Fisioterapia, Universidade Federal dos Vales do Jequitinhonha e Mucuri, Diamantina, Minas Gerais, Brazil; Programa Multicêntrico de Pós-Graduação em Ciências Fisiológicas, Sociedade Brasileira de Fisiologia, Diamantina, Brazil.
Insights
Obesity biomarkers like leptin and soluble tumor necrosis factor receptor 1 (sTNFR1) impact infant development. Higher sTNFR1 correlated with better cognitive and motor skills, while higher leptin levels were linked to reduced cognitive development in infants.
Area of Science:
- Pediatric Endocrinology
- Developmental Neuroscience
- Biomarker Research
Background:
- Obesity-related biomarkers may influence early childhood development.
- Understanding these associations is crucial for identifying early developmental risks.
Purpose of the Study:
- To investigate the relationship between obesity biomarkers and cognitive/motor development in infants aged 6-24 months.
Main Methods:
- Cross-sectional study of 50 infants.
- Measured plasma biomarkers including leptin, adiponectin, resistin, sTNFR1/2, BDNF, cortisol, and redox status.
- Assessed cognitive and motor development using the Bayley-III test and analyzed associations with regression models.
Main Results:
- Plasma leptin and sTNFR1 levels significantly associated with cognitive scores, explaining 37% of variability.
- Plasma sTNFR1 levels significantly associated with motor scores, explaining 24% of variability.
Conclusions:
- sTNFR1 levels correlate with enhanced cognitive and motor development in infants, independent of body weight.
- Elevated leptin levels are associated with reduced cognitive development in this age group.
Background:
This study aimed to verify the association between obesity-related biomarkers and cognitive and motor development in infants between 6 and 24 months of age.
Methods:
A cross-sectional study was conducted with 50 infants and plasma levels of leptin, adiponectin, resistin, soluble tumor necrosis factor receptors 1 and 2 (sTNFR1 and sTNFR2), chemokines, brain-derived neurotrophic factor (BDNF), serum cortisol and redox status were measured. The Bayley-III test was utilized to evaluate cognitive and motor development, and multiple linear stepwise regression models were performed to verify the association between selected biomarkers and cognitive and motor development.
Results:
A significant association was found among plasma leptin and sTNFR1 levels with cognitive composite scores, and these two independents variables together explained 37% of the variability of cognitive composite scores (p=0.001). Only plasma sTNFR1 levels were associated and explained 24% of the variability of motor composite scores (p=0.003).
Conclusions:
Plasma levels of sTNFR1 were associated with the increase in cognitive and motor development scores in infants between 6 and 24 months of age through a mechanism not directly related to excess body weight. Moreover, increase in plasma levels of leptin reduced the cognitive development in this age range.
Related Concept Videos
Obesity
Information Processing Approach
Biological Influences on Intelligence

